25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Viking Therapeutics Inc
Buy, Hold or Sell?

Let's analyze Viking Therapeutics Inc together

I guess you are interested in Viking Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Viking Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Viking Therapeutics Inc

I send you an email if I find something interesting about Viking Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of Viking Therapeutics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Viking Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€3.36
Expected worth in 1 year
€9.64
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
€6.27
Return On Investment
20.4%

For what price can you sell your share?

Current Price per Share
€30.83
Expected price per share
€23.18 - €41.61
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Viking Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)
€30.83
Intrinsic Value Per Share
€-9.83 - €-8.40
Total Value Per Share
€-6.47 - €-5.04

2.2. Growth of Viking Therapeutics Inc (5 min.)




Is Viking Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$348.4m$145.3m$203.1m58.3%

How much money is Viking Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$85.8m-$68.8m-$17m-19.8%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Viking Therapeutics Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Viking Therapeutics Inc?

Welcome investor! Viking Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Viking Therapeutics Inc.

First you should know what it really means to hold a share of Viking Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Viking Therapeutics Inc is €30.83. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Viking Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Viking Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €3.36. Based on the TTM, the Book Value Change Per Share is €1.57 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.70 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Viking Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.86-2.8%-0.86-2.8%-0.88-2.9%-0.69-2.2%-0.62-2.0%
Usd Book Value Change Per Share1.625.3%1.625.3%-0.72-2.3%-0.13-0.4%0.581.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share1.625.3%1.625.3%-0.72-2.3%-0.13-0.4%0.581.9%
Usd Price Per Share17.84-17.84-8.85-8.63-8.31-
Price to Earnings Ratio-20.79--20.79--10.05--12.48--14.04-
Price-to-Total Gains Ratio10.99-10.99--12.24--7.95--6.35-
Price to Book Ratio5.13-5.13-4.76-2.98-2.75-
Price-to-Total Gains Ratio10.99-10.99--12.24--7.95--6.35-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share31.902884
Number of shares31
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share1.62-0.13
Usd Total Gains Per Share1.62-0.13
Gains per Quarter (31 shares)50.32-4.15
Gains per Year (31 shares)201.29-16.62
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102011910-17-27
204033920-33-44
306045930-50-61
408057940-66-78
5010069950-83-95
60120811960-100-112
70140913970-116-129
80161015980-133-146
90181217990-150-163
100201320000-166-180

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.06.00.00.0%0.06.00.00.0%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%2.04.00.033.3%2.04.00.033.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.06.00.0%0.00.06.00.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%2.04.00.033.3%2.04.00.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Viking Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.5691.5690%-0.699+145%-0.130+108%0.561+180%
Book Value Per Share--3.3633.3630%1.795+87%2.915+15%3.098+9%
Current Ratio--19.19119.1910%7.611+152%22.747-16%30.023-36%
Debt To Asset Ratio--0.0540.0540%0.138-60%0.061-11%0.054+2%
Debt To Equity Ratio--0.0580.0580%0.160-64%0.067-14%0.059-2%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--1706564780.4001706564780.4000%646672311.100+164%700932373.428+143%660976501.568+158%
Eps---0.829-0.8290%-0.850+3%-0.663-20%-0.602-27%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--infinfnan%infnan%infnan%infnan%
Free Cash Flow Per Share---0.708-0.7080%-0.598-16%-0.506-29%-0.464-35%
Free Cash Flow To Equity Per Share--1.9111.9110%-0.546+129%0.050+3738%0.674+184%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---8.402--------
Intrinsic Value_10Y_min---9.831--------
Intrinsic Value_1Y_max---0.580--------
Intrinsic Value_1Y_min---0.728--------
Intrinsic Value_3Y_max---1.941--------
Intrinsic Value_3Y_min---2.423--------
Intrinsic Value_5Y_max---3.544--------
Intrinsic Value_5Y_min---4.363--------
Market Cap--1725961394.8001725961394.8000%669099555.900+158%714723094.708+141%673203555.435+156%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio9.167+44%5.1265.1260%4.764+8%2.980+72%2.753+86%
Pe Ratio-37.183-79%-20.792-20.7920%-10.054-52%-12.478-40%-14.038-32%
Price Per Share30.830+44%17.24017.2400%8.550+102%8.338+107%8.030+115%
Price To Free Cash Flow Ratio-43.527-79%-24.340-24.3400%-14.306-41%-16.456-32%-17.995-26%
Price To Total Gains Ratio19.653+44%10.99010.9900%-12.236+211%-7.948+172%-6.353+158%
Quick Ratio--16.02116.0210%5.415+196%19.794-19%26.632-40%
Return On Assets---0.233-0.2330%-0.409+75%-0.234+0%-0.207-11%
Return On Equity---0.247-0.2470%-0.474+92%-0.254+3%-0.224-9%
Total Gains Per Share--1.5691.5690%-0.699+145%-0.130+108%0.561+180%
Usd Book Value--348429703.432348429703.4320%145326464.292+140%243425077.789+43%252480755.971+38%
Usd Book Value Change Per Share--1.6231.6230%-0.723+145%-0.134+108%0.580+180%
Usd Book Value Per Share--3.4803.4800%1.857+87%3.016+15%3.205+9%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--1765953234.7581765953234.7580%669176507.526+164%725324820.023+143%683978483.823+158%
Usd Eps---0.858-0.8580%-0.880+3%-0.686-20%-0.623-27%
Usd Free Cash Flow---73378254.111-73378254.1110%-48398486.756-34%-43450334.753-41%-39334541.653-46%
Usd Free Cash Flow Per Share---0.733-0.7330%-0.618-16%-0.524-29%-0.480-35%
Usd Free Cash Flow To Equity Per Share--1.9781.9780%-0.565+129%0.052+3738%0.697+184%
Usd Market Cap--1786024851.3391786024851.3390%692384220.445+158%739595458.403+141%696631039.164+156%
Usd Price Per Share31.903+44%17.84017.8400%8.848+102%8.628+107%8.309+115%
Usd Profit---85897638.694-85897638.6940%-68869115.594-20%-56339130.685-34%-50626555.200-41%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share--1.6231.6230%-0.723+145%-0.134+108%0.580+180%
 EOD+4 -2MRQTTM+0 -0YOY+25 -65Y+21 -1010Y+18 -13

3.3 Fundamental Score

Let's check the fundamental score of Viking Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-37.183
Price to Book Ratio (EOD)Between0-19.167
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than116.021
Current Ratio (MRQ)Greater than119.191
Debt to Asset Ratio (MRQ)Less than10.054
Debt to Equity Ratio (MRQ)Less than10.058
Return on Equity (MRQ)Greater than0.15-0.247
Return on Assets (MRQ)Greater than0.05-0.233
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Viking Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose31.460
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Viking Therapeutics Inc

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Viking Therapeutics Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Viking Therapeutics Inc to the  industry mean.
  • A Net Profit Margin of 0.0% means that €0.00 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Viking Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.1.2. Return on Assets

Shows how efficient Viking Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Viking Therapeutics Inc to the  industry mean.
  • -23.3% Return on Assets means that Viking Therapeutics Inc generated €-0.23 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Viking Therapeutics Inc:

  • The MRQ is -23.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -23.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-23.3%TTM-23.3%0.0%
TTM-23.3%YOY-40.9%+17.6%
TTM-23.3%5Y-23.4%+0.1%
5Y-23.4%10Y-20.7%-2.7%
4.3.1.3. Return on Equity

Shows how efficient Viking Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Viking Therapeutics Inc to the  industry mean.
  • -24.7% Return on Equity means Viking Therapeutics Inc generated €-0.25 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Viking Therapeutics Inc:

  • The MRQ is -24.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -24.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-24.7%TTM-24.7%0.0%
TTM-24.7%YOY-47.4%+22.7%
TTM-24.7%5Y-25.4%+0.8%
5Y-25.4%10Y-22.4%-3.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Viking Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Viking Therapeutics Inc is operating .

  • Measures how much profit Viking Therapeutics Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Viking Therapeutics Inc to the  industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Viking Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.2.2. Operating Ratio

Measures how efficient Viking Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are €0.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Viking Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Viking Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Viking Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 19.19 means the company has €19.19 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Viking Therapeutics Inc:

  • The MRQ is 19.191. The company is very able to pay all its short-term debts. +2
  • The TTM is 19.191. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ19.191TTM19.1910.000
TTM19.191YOY7.611+11.580
TTM19.1915Y22.747-3.555
5Y22.74710Y30.023-7.276
4.4.3.2. Quick Ratio

Measures if Viking Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Viking Therapeutics Inc to the  industry mean.
  • A Quick Ratio of 16.02 means the company can pay off €16.02 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Viking Therapeutics Inc:

  • The MRQ is 16.021. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 16.021. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ16.021TTM16.0210.000
TTM16.021YOY5.415+10.606
TTM16.0215Y19.794-3.773
5Y19.79410Y26.632-6.838
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Viking Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Viking Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Viking Therapeutics Inc to industry mean.
  • A Debt to Asset Ratio of 0.05 means that Viking Therapeutics Inc assets are financed with 5.4% credit (debt) and the remaining percentage (100% - 5.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Viking Therapeutics Inc:

  • The MRQ is 0.054. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.054. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.054TTM0.0540.000
TTM0.054YOY0.138-0.083
TTM0.0545Y0.061-0.007
5Y0.06110Y0.054+0.008
4.5.4.2. Debt to Equity Ratio

Measures if Viking Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Viking Therapeutics Inc to the  industry mean.
  • A Debt to Equity ratio of 5.8% means that company has €0.06 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Viking Therapeutics Inc:

  • The MRQ is 0.058. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.058. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.058TTM0.0580.000
TTM0.058YOY0.160-0.102
TTM0.0585Y0.067-0.010
5Y0.06710Y0.059+0.009
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Viking Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Viking Therapeutics Inc to the  industry mean.
  • A PE ratio of -20.79 means the investor is paying €-20.79 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Viking Therapeutics Inc:

  • The EOD is -37.183. Based on the earnings, the company is expensive. -2
  • The MRQ is -20.792. Based on the earnings, the company is expensive. -2
  • The TTM is -20.792. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-37.183MRQ-20.792-16.390
MRQ-20.792TTM-20.7920.000
TTM-20.792YOY-10.054-10.739
TTM-20.7925Y-12.478-8.315
5Y-12.47810Y-14.038+1.560
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Viking Therapeutics Inc:

  • The EOD is -43.527. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -24.340. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -24.340. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-43.527MRQ-24.340-19.187
MRQ-24.340TTM-24.3400.000
TTM-24.340YOY-14.306-10.034
TTM-24.3405Y-16.456-7.884
5Y-16.45610Y-17.995+1.539
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Viking Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 5.13 means the investor is paying €5.13 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Viking Therapeutics Inc:

  • The EOD is 9.167. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.126. Based on the equity, the company is overpriced. -1
  • The TTM is 5.126. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD9.167MRQ5.126+4.041
MRQ5.126TTM5.1260.000
TTM5.126YOY4.764+0.362
TTM5.1265Y2.980+2.146
5Y2.98010Y2.753+0.227
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets368,490
Total Liabilities20,071
Total Stockholder Equity348,419
 As reported
Total Liabilities 20,071
Total Stockholder Equity+ 348,419
Total Assets = 368,490

Assets

Total Assets368,490
Total Current Assets367,225
Long-term Assets1,265
Total Current Assets
Cash And Cash Equivalents 55,516
Short-term Investments 306,563
Other Current Assets 2,522
Total Current Assets  (as reported)367,225
Total Current Assets  (calculated)364,601
+/- 2,624
Long-term Assets
Property Plant Equipment 1,126
Long-term Assets  (as reported)1,265
Long-term Assets  (calculated)1,126
+/- 139

Liabilities & Shareholders' Equity

Total Current Liabilities19,135
Long-term Liabilities936
Total Stockholder Equity348,419
Total Current Liabilities
Accounts payable 7,512
Total Current Liabilities  (as reported)19,135
Total Current Liabilities  (calculated)7,512
+/- 11,623
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,260
Long-term Liabilities  (as reported)936
Long-term Liabilities  (calculated)1,260
+/- 324
Total Stockholder Equity
Total Stockholder Equity (as reported)348,419
Total Stockholder Equity (calculated)0
+/- 348,419
Other
Capital Stock1
Common Stock Shares Outstanding 100,114
Net Invested Capital 348,419
Net Working Capital 348,090
Property Plant and Equipment Gross 1,126



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
> Total Assets 
302,312
284,256
256,502
210,662
168,529
368,490
368,490168,529210,662256,502284,256302,312
   > Total Current Assets 
302,133
283,501
256,104
210,528
167,040
367,225
367,225167,040210,528256,104283,501302,133
       Cash And Cash Equivalents 
24,779
8,377
29,117
26,371
36,632
55,516
55,51636,63226,37129,1178,37724,779
       Short-term Investments 
276,741
267,261
219,269
175,732
118,853
306,563
306,563118,853175,732219,269267,261276,741
       Other Current Assets 
0
0
0
619
3,411
2,522
2,5223,411619000
   > Long-term Assets 
179
755
398
134
1,489
1,265
1,2651,489134398755179
       Property Plant Equipment 
0
598
321
25
1,418
1,126
1,1261,418253215980
> Total Liabilities 
4,562
7,137
12,158
8,778
23,207
20,071
20,07123,2078,77812,1587,1374,562
   > Total Current Liabilities 
4,550
6,777
12,129
8,778
21,947
19,135
19,13521,9478,77812,1296,7774,550
       Accounts payable 
959
2,431
3,988
1,444
8,529
7,512
7,5128,5291,4443,9882,431959
   > Long-term Liabilities 
12
360
29
0
1,260
936
9361,26002936012
> Total Stockholder Equity
297,750
277,119
244,344
201,884
145,322
348,419
348,419145,322201,884244,344277,119297,750
   Common Stock000000
   Retained Earnings Total Equity000000
   Accumulated Other Comprehensive Income 000000
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 000000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-100,827
Operating Income-100,827-100,827
 
Operating Expense (+$)
Research Development63,806
Selling General Administrative37,021
Selling And Marketing Expenses-
Operating Expense100,827100,827
 
Net Interest Income (+$)
Interest Income15,020
Interest Expense--
Other Finance Cost-88
Net Interest Income14,932
 
Pretax Income (+$)
Operating Income-100,827
Net Interest Income14,932
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-85,895-100,827
EBIT - interestExpense = 0
-85,895
-85,895
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--85,895
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-85,895
Tax Provision--
Net Income From Continuing Ops-85,895-85,895
Net Income-85,895
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--14,932
 

Technical Analysis of Viking Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Viking Therapeutics Inc. The general trend of Viking Therapeutics Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Viking Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Viking Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 33.99 < 35.97 < 41.61.

The bearish price targets are: 29.81 > 23.41 > 23.18.

Tweet this
Viking Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Viking Therapeutics Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Viking Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Viking Therapeutics Inc.

Viking Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartViking Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Viking Therapeutics Inc. The current adx is .

Viking Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Viking Therapeutics Inc.

Viking Therapeutics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Viking Therapeutics Inc.

Viking Therapeutics Inc Daily Relative Strength Index (RSI) ChartViking Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Viking Therapeutics Inc.

Viking Therapeutics Inc Daily Stochastic Oscillator ChartViking Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Viking Therapeutics Inc.

Viking Therapeutics Inc Daily Commodity Channel Index (CCI) ChartViking Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Viking Therapeutics Inc.

Viking Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartViking Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Viking Therapeutics Inc.

Viking Therapeutics Inc Daily Williams %R ChartViking Therapeutics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Viking Therapeutics Inc.

Viking Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Viking Therapeutics Inc.

Viking Therapeutics Inc Daily Average True Range (ATR) ChartViking Therapeutics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Viking Therapeutics Inc.

Viking Therapeutics Inc Daily On-Balance Volume (OBV) ChartViking Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Viking Therapeutics Inc.

Viking Therapeutics Inc Daily Money Flow Index (MFI) ChartViking Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Viking Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-17STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-04MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-25ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-01-23MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-30STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Viking Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Viking Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose31.460
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Viking Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Viking Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Viking Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Viking Therapeutics Inc

I send you an email if I find something interesting about Viking Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Viking Therapeutics Inc.

Receive notifications about Viking Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.